[SRNE] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
09-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 339.37%
YoY- 136.27%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 11,753 5,778 4,105 121,910 2,243 1,103 1,276 44.73%
PBT -86,398 -74,002 -50,380 94,953 14,031 33,244 -7,605 49.87%
Tax 145 -221 -826 57,480 -195 35,323 2 104.06%
NP -84,023 -64,415 -47,328 33,959 14,373 -939 -7,605 49.18%
Tax Rate - - - -60.54% 1.39% -106.25% - -
Total Cost 95,776 70,193 51,433 87,951 -12,130 2,042 8,881 48.58%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin -714.91 -1,114.83 -1,152.94 27.86 640.79 -85.13 -596.00 3.07%
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -0.33 -0.49 -0.40 0.44 0.22 -0.03 -0.27 3.39%
EPS Diluted -0.33 -0.46 -0.40 0.44 0.22 -0.03 -0.27 3.39%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.